Navigation Links
Kronos Announces First Quarter Business Update and Financial Results
Date:11/15/2007

BELMONT, Mass., Nov 15 /PRNewswire-FirstCall/ -- Kronos Advanced Technologies, Inc. (OTC Bulletin Board: KNOS) President and Chief Executive Officer, Daniel R. Dwight, reported a business update and financial results for the three months ended September 30, 2007 on SEC Form 10-QSB.

Business Update

Commercial and Residential Products.

During the first fiscal quarter of 2008, Kronos executed a Letter of Intent for the development, manufacture and sale of air purification devices based upon Kronos' proprietary air movement and purification technology with a leading national retailer. It is expected that Kronos and the retailer would enter into a definitive purchase agreement providing for the exclusive sale of private label residential standalone air purifiers through the retailer's distribution channels. Actual purchases of the products are dependent on the successful development of the product, the negotiation of a definitive purchase agreement incorporating the terms of the letter of intent, other usual and customary terms and the retailer's discretion. Under the terms of the Letter of Intent, the retailer has paid Kronos a portion of the development costs of the new products and will contribute marketing resources to assist in the product development process. The intent of the parties is for Kronos to lead and manage all development, production and manufacturing activities for the Kronos air purifier and for the retailer to actively market the Kronos air purifier through its distribution channels.

In addition during the quarter, Kronos continued its development of a silent kitchen range hood application based on its proprietary technology. In October 2007, under the terms of a development agreement, Kronos shipped additional range hood prototypes to a global consumer products customer for testing and evaluation.

Medical Products.

During the quarter, Kronos earned $25,000 in revenue from licensing fees from its license agre
'/>"/>

SOURCE Kronos Advanced Technologies, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
7. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
8. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
9. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
10. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
11. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)MORRISTOWN, N.J., Dec. 4 Watson Pharmaceuticals, Inc. (NYSE: WPI ), a leading global specialty pharmaceutical company, today confirmed that its subsidiary, Watson Laboratories, Inc.-Florida, filed
(Date:12/4/2009)WILMINGTON, Del., Dec. 4 AstraZeneca (NYSE: AZN ) today announced that the US Food and Drug Administration (FDA) has approved once-daily SEROQUEL XR® (quetiapine fumarate) Extended Release Tab
(Date:12/3/2009)ALISO VIEJO, Calif. and STATE COLLEGE, Pa., Dec. 3 Ambry Genetics and SoftGenetics today announced the signing of an agreement to provide extended bioinformatics genomics services using SoftGenetics,
Breaking Medicine Technology:Watson Files FDA Application for Generic Rozerem(R) 2Watson Files FDA Application for Generic Rozerem(R) 3US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 2US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 3US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 4US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 5US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 6US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 7US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 8US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 9Ambry Genetics and SoftGenetics Form Exclusive Alliance for Extended Bioinformatics Support for Next Generation Sequencing Projects 2Ambry Genetics and SoftGenetics Form Exclusive Alliance for Extended Bioinformatics Support for Next Generation Sequencing Projects 3Energy saving powder 10692 1Energy saving powder 10692 2Energy saving powder 10692 3Exploration by explosion 3A Studying the inner realm of living cells 10689 1Eisai Donates More Than 80 Murals to Hospitals Around the United States 61147 1Eisai Donates More Than 80 Murals to Hospitals Around the United States 61147 2Eisai Donates More Than 80 Murals to Hospitals Around the United States 61147 3
...ry(1) in the current issue of The Journal of Infec...egalovirus (CMV) said the vaccine under,developmen...ptimal dose and,regimen tested, "holds promise" ba...ponses in a majority of CMV-seronegative subjects,... to prevent infection and disease. The,commentary ...
...c.,(OTC Bulletin Board: ANPG), reported today that...(ESI) announced that the U.S. Environmental,Protec...dditional claims to,its disinfectant/sanitizer, En...gainst the "superbug" MRSA (scientifically known a... VRE (scientifically known as,Vancomycin Resistant...
Other Medicine Technology:Promise of Vical's CMV Vaccine Noted by Independent Experts 2Promise of Vical's CMV Vaccine Noted by Independent Experts 3Promise of Vical's CMV Vaccine Noted by Independent Experts 4Anpath Group, Inc. Announces Addition of MRSA and VRE Claims for Its EnviroTru(R) Disinfectant 2Anpath Group, Inc. Announces Addition of MRSA and VRE Claims for Its EnviroTru(R) Disinfectant 3Anpath Group, Inc. Announces Addition of MRSA and VRE Claims for Its EnviroTru(R) Disinfectant 4
(Date:12/5/2009)AVIVA today announced the launch of International Solutions, an innovative new international private medical insurance plan which follows the acclaimed modular design of its UK equivalent. In addition
(Date:12/4/2009)NEW YORK, Dec. 4 Care Investment Trust Inc. (NYSE: CRE ) ("Care" or the "Company") today announced that its Board of Directors has declared a dividend of $0.17 per share of common stock. The div
(Date:12/4/2009)WASHINGTON, Dec. 4 The American Association of Homes and Services for the Aging (AAHSA) applauds the Senate for ensuring that the Community Living and Supportive Services (CLASS) provisions remain i
(Date:12/4/2009)ANAHEIM, Calif., Dec. 4 Pamela Bowen, Chief Information Officer at Crescent Healthcare, was selected as a finalist for the "Chief Innovation Officer" Appy Award for transforming Crescent,s business w
(Date:12/4/2009)STANFORD, Calif. A new study shows that muscle cells grown in the lab can restore an intestine,s ability to squeeze shut properly. The work, performed in dogs and rats, might ultimately help treat pa
Breaking Medicine News(10 mins):Health News:AVIVA's Private Health Insurance Products Solutions Go International 2Health News:Care Investment Trust Inc. Declares Quarterly Dividend of $0.17 Per Share 2Health News:Crescent CIO '09 Dreamforce Conference Speaker and Award Finalist 2Health News:Muscle cell infusion shown to strengthen sphincters in animals in Stanford study 2Health News:Muscle cell infusion shown to strengthen sphincters in animals in Stanford study 3Health News:Muscle cell infusion shown to strengthen sphincters in animals in Stanford study 4
...Turner Construction Company, the nation,s largest ...d to construct a $441 million replacement hospital...P) in Plainsboro Township, N.J. , , The scope of... linear accelerators and related ancillary and sup...
...ing with a female mouse can extend the reproductiv...ccording to a study conducted by Ralph Brinster an... Pennsylvania School of Veterinary Medicine. The ...the spermatogonial stem cells likely occurs throug...
.... 22 Nearly 2,500 dentists, dental,hygienists, de...Carolina are,expected to take part in the sixth an... 6, 2009, in what promises to be among the largest...cs and community colleges across the,state to trea...
...ight into a built-in volume-control system, , ...t a natural earplug: Your ears appear to be able t...rotect your hearing, and a new study provides mor...rom dangerous noise, said study author Paul Fuchs,...
...arly free events offered this Saturday, January 24... history-making celebration where yogis, novices, ...ryone in between join together to stretch mind, bo...classes and workshops are free -- or nearly free. ...
...n recent years, genetic studies have uncovered hun... such as cancer or diabetes, raising the prospect ...formation in an individual,s genome. ,But the vari...This disappointment has led geneticist Barak Cohen...
Other Medicine News:Health News:Turner Selected to Construct Replacement Hospital for University Medical Center at Princeton 2Health News:Living with females extends the reproductive life of the male mouse, says Penn veterinary researcher 2Health News:Living with females extends the reproductive life of the male mouse, says Penn veterinary researcher 3Health News:North Carolina Dentists Team Up To Treat Needy Children 2Health News:How the Ear Protects Your Hearing 2Health News:Yoga Day USA Changes Lives and Builds Community 2Health News:Genetic interactions are the key to understanding complex traits 2Health News:Genetic interactions are the key to understanding complex traits 3
Common Duct Exploration Set: With N-Circle® Nitinol Tipless Stone Extractor
MAMMOTOME® HH (Hand Held): 8 Gauge Probe
...wound support. Especially suitable for instances i... is desired and containment of wound transudate is... 910 has been found to be inert, nonantigenic, and...mesh is prepared from a synthetic absorbable copol...
...ing walls of tissue are in direct contact with a s... valleys and ridges means less tissue remodeling t...Forming Plug design fills more of the defect with ... for faster healing and defect containment.,Only ...
Medicine Products: